Extended Adjuvant Tamoxifen for Early Breast Cancer: A Meta-Analysis

• Mustafa Al-Mubarak,

  Affiliations Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada, Ministry of Higher Education, Riyadh, Saudi Arabia

  ⨯
• Ariadna Tibau,

  Affiliation Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada

  ⨯
• Arnoud J. Templeton,

  Affiliation Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada

  ⨯
• David W. Cescon,

  Affiliation Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada

  ⨯
• Alberto Ocana,

  Affiliation Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain

  ⨯
• Bostjan Seruga,

  Affiliation Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

  ⨯
• Eitan Amir

  * E-mail: eitan.amir@uhn.ca

  Affiliation Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada

  ⨯